Detalhe da pesquisa
1.
Pharmacokinetic Model of Tenofovir and Emtricitabine and Their Intracellular Metabolites in Patients in the ANRS 134-COPHAR 3 Trial Using Dose Records.
Antimicrob Agents Chemother
; 67(5): e0233918, 2023 05 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37098914
2.
Cerebrospinal fluid exposure to bictegravir/emtricitabine/tenofovir in HIV-1-infected patients with CNS impairment.
J Antimicrob Chemother
; 76(12): 3280-3285, 2021 11 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34508640
3.
Characteristics of Dolutegravir and Bictegravir Plasma Protein Binding: a First Approach for the Study of Pharmacologic Sanctuaries.
Antimicrob Agents Chemother
; 64(11)2020 10 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-32868324
4.
Effect of high-dose rifampicin on efavirenz pharmacokinetics: drug-drug interaction randomized trial.
J Antimicrob Chemother
; 75(5): 1250-1258, 2020 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31999314
5.
Comparison of the effect of direct-acting antiviral with and without ribavirin on cyclosporine and tacrolimus clearance values: results from the ANRS CO23 CUPILT cohort.
Eur J Clin Pharmacol
; 75(11): 1555-1563, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31384986
6.
Pharmacokinetics of efavirenz in patients on antituberculosis treatment in high human immunodeficiency virus and tuberculosis burden countries: A systematic review.
Br J Clin Pharmacol
; 84(8): 1641-1658, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29624706
7.
Genetics of Nevirapine Metabolic Pathways at Steady State in HIV-Infected Cambodians.
Antimicrob Agents Chemother
; 61(12)2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28947469
8.
Favipiravir Pharmacokinetics in Nonhuman Primates and Insights for Future Efficacy Studies of Hemorrhagic Fever Viruses.
Antimicrob Agents Chemother
; 61(1)2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27736754
9.
Pharmacokinetics of Raltegravir in HIV-Infected Patients on Rifampicin-Based Antitubercular Therapy.
Clin Infect Dis
; 61(8): 1328-35, 2015 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26105170
10.
High Cure Rate With 24 Weeks of Daclatasvir-Based Quadruple Therapy in Treatment-Experienced, Null-Responder Patients With HIV/Hepatitis C Virus Genotype 1/4 Coinfection: The ANRS HC30 QUADRIH Study.
Clin Infect Dis
; 61(5): 817-25, 2015 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25977266
11.
Raltegravir Pharmacokinetics in Patients on Asunaprevir-Daclatasvir.
Antimicrob Agents Chemother
; 59(12): 7903-5, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26438504
12.
Nevirapine or efavirenz for tuberculosis and HIV coinfected patients: exposure and virological failure relationship.
J Antimicrob Chemother
; 70(1): 225-32, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25239466
13.
Dependence of efavirenz- and rifampicin-isoniazid-based antituberculosis treatment drug-drug interaction on CYP2B6 and NAT2 genetic polymorphisms: ANRS 12154 study in Cambodia.
J Infect Dis
; 209(3): 399-408, 2014 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23990572
14.
Pharmacokinetic study of raltegravir in HIV-infected patients with end-stage liver disease: the LIVERAL-ANRS 148 study.
Clin Infect Dis
; 59(8): 1177-84, 2014 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24992955
15.
Characterization of binding of raltegravir to plasma proteins.
Antimicrob Agents Chemother
; 57(10): 5147-50, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23856784
16.
Pharmacokinetics of phase I nevirapine metabolites following a single dose and at steady state.
Antimicrob Agents Chemother
; 57(5): 2154-60, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23459477
17.
Adherence profiles and therapeutic responses of treatment-naive HIV-infected patients starting boosted atazanavir-based therapy in the ANRS 134-COPHAR 3 trial.
Antimicrob Agents Chemother
; 57(5): 2265-71, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23459496
18.
Erratum for Madelain et al., "Favipiravir Pharmacokinetics in Nonhuman Primates and Insights for Future Efficacy Studies of Hemorrhagic Fever Viruses".
Antimicrob Agents Chemother
; 62(1)2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29269432
19.
Multiple genetic variants predict steady-state nevirapine clearance in HIV-infected Cambodians.
Pharmacogenet Genomics
; 22(12): 868-76, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23104099
20.
Presence of lamivudine or emtricitabine is associated with reduced emergence of nonnucleoside reverse transcriptase inhibitor mutations in an efavirenz-based intermittent antiretroviral treatment regimen.
Antimicrob Agents Chemother
; 56(3): 1655-7, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22203586